J&J Wins EU Nod For Akeega To Go Up Against AZ/MSD’s Lynparza In First-Line mCRPC

With BRCA-Mutated Niche

 
• By Ayisha Sharma
  
Lots of yellow squares, one white circle shaded in, representing niche
Akeega's Strong Efficacy In BRCA-Mutated Patients Carves A Niche • Source: Shutterock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip